Melanoma Stage III Clinical Trials
0 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 1Phase 2
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Metastatic MelanomaMelanoma Stage IVMelanoma Stage III+1 more
Perspective Therapeutics300 enrolled13 locationsNCT05655312
Recruiting
Phase 2
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
MelanomaMelanoma Stage IVMelanoma (Skin)+1 more
University of California, Irvine14 enrolled1 locationNCT06771544
Recruiting
Early Phase 1
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
Melanoma Stage IVBRAF V600 MutationMelanoma Stage III
H. Lee Moffitt Cancer Center and Research Institute50 enrolled1 locationNCT04741997
Recruiting
Phase 2
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Melanoma Stage IVInoperable DiseaseMelanoma Stage III
H. Lee Moffitt Cancer Center and Research Institute29 enrolled1 locationNCT04562129
Recruiting
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
MelanomaUnresectable MelanomaMelanoma Stage IV+1 more
University of Wisconsin, Madison24 enrolled1 locationNCT06199713
Recruiting
Phase 2
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
MelanomaAdvanced MelanomaMelanoma Stage IV+1 more
H. Lee Moffitt Cancer Center and Research Institute90 enrolled1 locationNCT06295159
Recruiting
Not Applicable
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
Melanoma Stage IVPediatric ALLMelanoma Stage III+4 more
Miltenyi Biomedicine GmbH40 enrolled7 locationsNCT06508775
Recruiting
Not Applicable
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
Melanoma Stage IVMelanoma Stage III
Kelly McMasters30 enrolled1 locationNCT04513028
Recruiting
Phase 2
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage IVMelanoma Stage III
University of California, San Francisco25 enrolled2 locationsNCT04598009
Recruiting
Phase 1
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
MelanomaMelanoma Stage IVMelanoma Stage III
Inge Marie Svane10 enrolled2 locationsNCT06204991
Recruiting
Phase 1Phase 2
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
CancerCutaneous MelanomaMelanoma Stage IV+1 more
Krystal Biotech, Inc.240 enrolled15 locationsNCT05970497
Recruiting
Phase 1Phase 2
FMT to Convert Response to Immunotherapy
Melanoma Stage IVMelanoma Stage III
The Netherlands Cancer Institute24 enrolled1 locationNCT05251389
Recruiting
Not Applicable
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
ImmunotherapyMelanoma Stage IVMelanoma Stage III+1 more
Erasmus Medical Center80 enrolled1 locationNCT05652673
Recruiting
Versatile Ampification Single-Molecule Detection in Liquid Biopsy
Melanoma Stage IVMelanoma (Skin)Melanoma Stage III+1 more
Regina Elena Cancer Institute20 enrolled1 locationNCT05940311
Recruiting
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Melanoma Stage IVMelanoma Stage III
Pierre Fabre Pharma GmbH750 enrolled59 locationsNCT04045691